Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v31-EN Version v18-FR
Language English French
Date Updated 2020-04-06 2019-06-12
Drug Identification Number 02326965 02326965
Brand name SANDOZ CANDESARTAN SANDOZ CANDESARTAN
Common or Proper name CANDESARTAN CANDESARTAN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CANDESARTAN CILEXETIL CANDESARTAN CILEXETIL
Strength(s) 8MG 8MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 3X10/Bl 3X10/Bl
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-09-20 2018-09-20
Estimated end date 2020-05-04 2019-09-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments